The role of immune therapies in treatment of ALL patients

Immune therapies have emerged as promising approaches in the treatment of Acute Lymphoblastic Leukemia (ALL) patients, particularly for those who may not respond well to conventional chemotherapy or who experience relapse. These therapies harness the power of the immune system to target and eliminate leukemia cells. Several types of immune therapies are being investigated and utilized in the treatment of ALL...